Gliptins.
Mikhail
Nasser
N
D000077270:Exenatide; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D009325:Nausea / Q000139:chemically induced*; D010352:Patient Dropouts / Q000706:statistics & numerical data*; D010455:Peptides / Q000009:adverse effects*; D014688:Venoms / Q000009:adverse effects*
D007004:Hypoglycemic Agents; D010455:Peptides; D014688:Venoms; D000077270:Exenatide